250+ investors that invest in your industry and stage Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Finance
Retail
Infrastructure
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Theatre
Oil and Gas
Fashion
Non Profit
Renewable Energy
Sporting Goods
Celebrity
Social Impact
Restaurants
Cryptocurrency
SaaS
Machine Learning
Blockchain
Agriculture (AgTech)
Media (Entertainment)
Facebook
Beauty
Publishing
Food and Beverage
Social Network
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Real Estate
Life Science
B2B
Enterprise
Software
Film
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Nigeria
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Romania
Bangladesh
Algeria
Kenya
Kazakhstan
Cayman Islands
Cambodia
Oman
Cameroon
Guatemala
Colombia
Seychelles
China
Ireland
New Zealand
Cyprus
India
Germany
Canada
United Kingdom
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
United States
Japan
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Find investors

Top 50 Biotechnology Angel Investors in United Kingdom (June 2026)

The most active angel investors investing in United Kingdom Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
30 United Kingdom, United States, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $537k–$56M
Nadav Rosenberg
Angel
5 United Kingdom, France, Israel Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Software $850k–$19M
Peder Nielsen
Angel
3 United Kingdom Seed, Convertible Note Biotechnology, Machine Learning
Ian Hogarth
Angel
3 United Kingdom, United States, Germany Seed, Series A, Pre-Seed Software, E-Commerce, Artificial Intelligence $668k–$28M
Stefano Bernardi
Angel
3 Italy, United Kingdom, France Seed, Pre-Seed Software, Biotechnology, Artificial Intelligence $100k–$45M
DrPano Kroko Churchill
Angel
3 United Kingdom Angel, Series A Health Care, Therapeutics, Biotechnology $150k–$458k
Charlie Songhurst
Angel
3 United Kingdom, United States, Germany Seed, Pre-Seed Software, Information Technology, Artificial Intelligence $510k–$6.8M
Paul Wicks
Angel
3 United Kingdom, United States, Japan Seed, Pre-Seed, Series A Software, Wellness, E-Commerce $539k–$11M
Jeff Dean
Angel
3 United States, United Kingdom, Japan Seed, Series A, Pre-Seed Artificial Intelligence, Information Technology, Software $450k–$53M
Jude Gomila
Angel
3 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$4.7M
Milad Alucozai
Angel
3 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $110k–$55M
Darrin Disley
Angel
3 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $458k–$3.7M
Damien Lane
Angel
2 United Kingdom, United States, Ireland Seed, Pre-Seed, Series A SaaS, Software, Health Care $459k–$16M
Ed Parkinson
Angel
2 United Kingdom Seed Software, Health Care, Life Science $1.8M–$3.3M
Amar Shah
Angel
2 United Kingdom, Poland, Germany Pre-Seed, Seed, Angel Artificial Intelligence, Software, Health Care $642k–$15M
Inaki Berenguer
Angel
2 Spain, United States, United Kingdom Seed, Angel, Pre-Seed FinTech, E-Commerce, Financial Services $233k–$8.5M
Serge Chiaramonte
Angel
2 United Kingdom, United States, France Seed, Pre-Seed FinTech, Financial Services, Information Technology $637k–$38M
Patrick Pichette
Angel
2 United Kingdom, Germany, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $750k–$95M
Chris Mairs
Angel
2 United Kingdom, United States Seed, Pre-Seed, Angel Software, FinTech, Financial Services $334k–$3.9M
Tim Dempsey
Angel
2 United Kingdom Seed, Series A Software, SaaS, Financial Services $962k–$2.5M
Aidan Gomez
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $1.8M–$12M
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed, Series C Software, E-Commerce, Health Care $1.4M–$24M
Bradley Horowitz
Angel
2 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $150k–$120M
Nadav Ben-Chanoch
Angel
2 United States, United Kingdom, France Seed, Pre-Seed Software, Information Technology, Health Care $125k–$5.5M
Jon Oringer
Angel
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Information Technology, Health Care $100k–$31M
Pratima Aiyagari
Angel
2 United Kingdom, France, Croatia Seed, Pre-Seed, Series A Analytics, Cyber Security, SaaS $982k–$12M
Ariel Poler
Angel
2 United States, Spain, Mexico Seed, Series A, Angel Software, Social Media, Internet $455k–$7.9M
Edward Lando
Angel
2 United States, France, United Kingdom Seed, Pre-Seed Software, Health Care, Information Technology $125k–$6.6M
Paul Forster
Angel
2 United Kingdom, Germany, United States Seed, Series A, Pre-Seed Software, FinTech, Financial Services $1.1M–$15M
Mati Staniszewski
Angel
2 United States, United Kingdom, Poland Seed, Pre-Seed, Series A Artificial Intelligence, Software, SaaS $2M–$40M
Hugh Grant
Angel
2 United Kingdom Seed Biotechnology, Machine Learning
Jim Mellon
Angel
2 United States, United Kingdom, Germany Series A, Seed Biotechnology, Food and Beverage, Health Care
Gilad Engel
Angel
2 France, Israel, United Kingdom Seed, Pre-Seed Hardware, Analytics, Biotechnology $1.2M–$1.9M
Robert Kopple
Angel
2 United States, United Kingdom Convertible Note FinTech, Finance, Life Science
Mark P. Stevenson
Angel
1 United Kingdom Seed Medical, Genetics, Health Care
David Rowan
Angel
1 United Kingdom, Germany, Croatia Seed, Pre-Seed Software, Artificial Intelligence, Information Technology
Sami Mikati
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science
Johnathan Matlock
Angel
1 United Kingdom Seed, Pre-Seed Biotechnology, Medical, Health Care
Sarah Howell
Angel
1 United Kingdom Post-IPO Equity Biopharma, Education, Biotechnology
Mark Gillespie
Angel
1 United States, United Kingdom, India Seed, Series B Music, Internet, Video
Brad Wilson
Angel
1 United Kingdom Seed Health Care, Biotechnology, Machine Learning
Martin Chavez
Angel
1 United States, United Kingdom Series A, Seed, Private Equity Health Care, Machine Learning, Biotechnology
Ahmed Medhat
Angel
1 United States, United Kingdom Seed, Pre-Seed Information Technology, Apps, Manufacturing
Huw Bishop
Angel
1 United Kingdom Angel EdTech, Training, E-Learning
Sam Harris
Angel
1 United Kingdom Pre-Seed Wellness, Elder Care, Health Care
Dave DeWalt
Angel
1 United States, Israel, United Kingdom Series C, Series A Cyber Security, Security, Network Security
Peer Schatz
Angel
1 United States, United Kingdom Seed Medical, Genetics, Health Care
Susan Lowther
Angel
1 United Kingdom Post-IPO Equity Biopharma, Education, Biotechnology
Sam Fazeli
Angel
1 United Kingdom Post-IPO Equity Biopharma, Education, Biotechnology
Silla Scheepens
Angel
1 United Kingdom Seed Biotechnology, Food Processing, Food and Beverage
Access all 178 angel investors in United Kingdom Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 30 investments in United Kingdom Biotechnology startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 61
  • Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
  • Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 5 investments in United Kingdom Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$19M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
Show all investments...

Peder Nielsen
Angel · Copenhagen, Hovedstaden, Denmark · 3 investments in United Kingdom Biotechnology startups

Peder Nielsen - Member of the Global Advisors Network @ Global Bio Fund

Show more...

Investment focus

  • Industry: Biotechnology, Machine Learning
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 3 investments in United Kingdom Biotechnology startups

Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 55
  • Round size: Seed $1.5M–$8.8M; Pre-Seed $668k–$7.7M; Series A $11M–$28M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Blloc — The ultimate smartphone experience. Boost your productivity. Focus on what matters.
  • Cordless — Bridging the gap between voice and text
  • Heygo — Explore places to visit within the UK and around the world on Rest Less. Get inspired and plan trips to holiday destinations with us.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotechnology startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 17
  • Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Show all investments...

DrPano Kroko Churchill
Angel · Seattle, Washington, United States · 3 investments in United Kingdom Biotechnology startups

Pano Kroko is a legendary entrepreneur, Angel, VC and PE investor in innovation towards solving big problems. His investment emphasis is on Life Sciences, Biotech, Therapeutics, Medicine, Internet, Mobile, Communications, Clean Technology, Renewable Energy, and Environmental Finance. We have a quarterly Business Plan competition for placementin our early stage start up accelerator in Seattle Washington. We also run a program in Washington DC, and we have an Innovation Master Class Startup Weekend that runs Ten times a year in Seattle, Beijing, Silicon Valley, and in major Universities around the world.The Accelerator in Seattle & Silicon Valley is called American Angels, and the Accelerator in Washington DC is named H2O and both accept business plans and great ideas with Founders, and Executive teams right now. We would like to see StartUps in all of our areas of focus as well as anything else that is great and promising to solve Big Problems. Parallel to this we also run the CEP - Clean Energy Program incubator in Oxford UK, and the Biotech accelerator for genetics, stem cell applications, genomics, medicine, pharma and telomeres research in Cambridge UK.For our more traditional VC and PE work in the US, the American Venture Company in the US and the Investment Bank Green Capital Inc in the UK and Europe. These are our conduits of support for companies and also the Green Bonds Investments Plc. All of our organizations act as levers of positive change for impact investing, and as corporate environmental investment responsibility -- within the Finance community.In Seattle and in Silicon Valley we run the Accelerator and Early Stage Investment firm AMERICAN ANGELS where we have monthly pitches and demos for new StartUps and we also run a CEO roundtable to help promising Entrepreneurial leaders to succeed.If you or your company is interested in cooperation, presenting, funding, deal syndication or simply for submission of Executive Summaries and Business Plans for early stage angel funding and/or inclusion in the H2O Incubator/Accelerator or the Clean Energy program and the Biotech incubator, please contact us herewith: Mr Ruddy Wallace: envpar [at] gmail.com

Show more...

Investment focus

  • Industry: Health Care, Therapeutics, Biotechnology
  • Stage:Angel, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Angel $150k–$458k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amrit Advanced Biotech — Company working in Genetics, Telomeres health applications, cancer mitigation and lengthening of....
Show all investments...

Charlie Songhurst
Angel · Greater Seattle Area, Washington, United States · 3 investments in United Kingdom Biotechnology startups

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 177
  • Round size: Seed $1.1M–$6.8M; Pre-Seed $510k–$5.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
  • Hyphen SCS — Find and rent verified warehouses across 992+ cities in India. Compare 65,000+ listings on Hyphen SCS.
  • Interface — Interface is an AI-native Document Management System for High Hazard Industries.
Show all investments...

Paul Wicks
Angel · London, England, United Kingdom · 3 investments in United Kingdom Biotechnology startups

Paul Wicks, Ph.D., is a strategic advisor and independent consultant who helps digital health and life science companies turn data into evidence, evidence into influence, and influence into impact. He has supported over 40 organizations including AstraZeneca, Ada Health, Biogen, Click Therapeutics, and Woebot.Previously, Paul spent 13 years as VPof R&D at PatientsLikeMe, building one of the world’s largest patient communities and pioneering decentralized trials, digital biomarkers, and real-world evidence. He has authored over 200 peer-reviewed papers and served on editorial boards of journals including the BMJ, Digital Biomarkers, and BMC Medicine.A neuropsychologist by training, Paul completed his Ph.D. at King’s College London and a postdoc on the psychology of Parkinson’s disease. His work has been featured by BBC, CNN, and The New York Times. He was named MIT Technology Review’s “Humanitarian of the Year” in 2011 and is a TED Fellow and FLIER alumnus of the Academy of Medical Sciences. He is an honorary Professor at the University of Birmingham.

Show more...

Investment focus

  • Industry: Software, Wellness, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 17
  • Round size: Seed $3M–$6.6M; Pre-Seed $539k–$1M; Series A $6.9M–$11M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Epiminds — Epiminds develops multi-agent AI systems to run marketing end-to-end.
  • Run Yourself — RunYourself is a prompt-driven, AI-assisted platform making it easy for managers to have effective coaching conversations. We blend expert coaching prompts on a spectrum of crucial topics with AI-powered support. This enables managers to have productive peer coaching conversations with other managers and more effective coaching, feedback, performance and career development conversations with their team members.
  • MakeSense Technology — MakeSense is a team of tech experts, empowering people who are blind or have low vision.
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 3 investments in United Kingdom Biotechnology startups

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 87
  • Round size: Seed $2.3M–$35M; Pre-Seed $450k–$3M; Series A $6.1M–$53M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Altara — Altara is a San Francisco–based startup building a scientific-intelligence AI platform that analyzes complex physical-science and engineering data (batteries, chips, materials, etc.) to speed up R&D and failure analysis.
  • Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
  • depthfirst — An AI-native security platform that understands your code, business logic, and infrastructure to find more vulnerabilities, slash false positives, and give developers actionable fixes in their workflow.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotechnology startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 55
  • Round size: Seed $1.4M–$4.7M; Angel $190k–$1.3M; Pre-Seed $1M–$2.8M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
  • Athens Research — Open-Source Roam Research. A private, extensible, and community-driven knowledge graph.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Milad Alucozai
Angel · San Francisco, California, United States · 3 investments in United Kingdom Biotechnology startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Round size: Seed $150k–$6.7M; Pre-Seed $110k–$1.5M; Series A $13M–$55M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 3 investments in United Kingdom Biotechnology startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $458k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 38
  • Round size: Seed $459k–$3.1M; Pre-Seed $605k–$1M; Series A $3.2M–$16M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Calira — Calira (formerly Clustermarket). Give researchers an easy way to book equipment, improve equipment utilisation, and get structured lab usage data.
  • Realla — Search the entire commercial property market for offices, serviced office space, retail, industrial for sale and to rent
  • IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
Show all investments...

Ed Parkinson
Angel · 2 investments in United Kingdom Biotechnology startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $1.8M–$3.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Amar Shah
Angel · San Diego, California, United States · 2 investments in United Kingdom Biotechnology startups

Amar Shah is based out of London and is the Founder & Partner of Dhyan VC. Amar previously worked at Firstminute Capital as an Entrepreneur In Residence. Amar Shah attended the University of Cambridge.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United Kingdom, Poland, Germany

Investor stats

  • Total investments: 10
  • Round size: Seed $4.8M–$15M; Pre-Seed $642k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TextCortex — Create the highest quality content 7x faster, using TextCortex AI - the best copywriting tool for all your content. Get started for free, no credit card required.
  • PHINXT Robotics — PHINXT Robotics enables warehouses of any size to deploy autonomous robots as needed, with no expertise required.
  • Martian Lawyers Club — Home of GUG and Nomic
Show all investments...

Inaki Berenguer
Angel · New York, New York, United States · 2 investments in United Kingdom Biotechnology startups

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Show more...

Investment focus

  • Industry: FinTech, E-Commerce, Financial Services
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Seed $500k–$8.5M; Angel $233k–$1M; Pre-Seed $1.2M–$2M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Ukio — Artfully designed fully furnished apartments available for extended stays
  • Paack — Online sales growth and customer satisfaction are hampered by inadequate delivery experiences. Existing last mile delivery companies are incapable of providing a truly customer-centric approach. Our proprietary technology stack and operational excellence is built specifically to service time slot deliveries, controlled entirely by the endcustomer. This creates unprecedented results through basket conversion, loyalty, repeat purchase, acquisition, brand image and customer satisfaction, plus they can actually help the environment.Paack operates in Europe (UK, France, Spain and Portugal).
  • Solid Financial Technologies, Inc — Instantly create bank accounts, send payments and issue cards, powered by the Solid Platform. Embedded Banking. Banking as a Service (BaaS) | Payments as a Service | Cards as a Service | Compliance as a Service
Show all investments...

Serge Chiaramonte
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Serge Chiaramonte

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 57
  • Round size: Seed $1.2M–$5.3M; Pre-Seed $637k–$38M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Desia — Desia provides advanced AI applications for productivity, automation, and analytics for financial services.
  • qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
  • Tranched — Introducing real-time on-chain securitisation. Fintech Lenders and Professional Investors can now launch an institutional-grade transaction up to 90% faster than before.
Show all investments...

Patrick Pichette
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Patrick Pichette is based out of London, England, and is the Partner of Inovia Capital and also Board Member of Cohere. Patrick Pichette previously worked at Twitter as a Board of Directors. Patrick Pichette attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $750k–$10M; Series A $10M–$95M; Series B $15M–$95M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Kaedim — AI-powered 3D asset creation service delivering fast, production-ready 3D assets. Scale 3D pipelines without hiring, accelerate 3D game art production, and reduce 3D asset costs by up to 90%.
  • Apheris — Superior drug discovery models through federated data networks
  • made of air — Made of Air is a carbon-negative materials company. They take low-value wood waste and transform it into high-value, carbon-negative thermoplastics. These thermoplastics can be formed with all traditional heat-forming methods and used for a wide variety of applications, turning manufactured goods into engineered carbon sinks.
Show all investments...

Chris Mairs
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Chris Mairs - Venture Partner @ Entrepreneurs First

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 25
  • Round size: Seed $655k–$3.9M; Angel $334k–$707k; Pre-Seed $917k–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • nMachine — A Low-Code solution for creating extraordinary Day 2 Operations platforms - called nMachines - for your existing Kubernetes-based applications, that can be shared inside and outside your organization.
  • Incard — Welcome to the world's first payment solution designed exclusively for e-commerce, entrepreneurs, dropshippers and influencers. Join our waitlist now.
  • Tuza — Find the right card machine for your business, with good rates and the best features. Search the top providers in minutes, including Worldpay, Barclaycard, Tyl and Teya.
Show all investments...

Tim Dempsey
Angel · 2 investments in United Kingdom Biotechnology startups

Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.

Show more...

Investment focus

  • Industry: Software, SaaS, Financial Services
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Seed $962k–$2.5M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Lunio — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
  • Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
  • PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Aidan Gomez
Angel · Oxford, Arkansas, United States · 2 investments in United Kingdom Biotechnology startups

Aidan Gomez is based out of Toronto, Ontario and is the co-founder & CEO at Cohere. Aidan Gomez attended the University of Oxford.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 17
  • Round size: Seed $2.4M–$12M; Pre-Seed $1.8M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Extropic AI — The next era of computing isn't dead. It's alive. More coming soon.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Helical — The full power of DNA & (m)RNA Bio Foundation Models in one open-core platform. Accelerate Drug Discovery with AI.
Show all investments...

Mark Evans
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Series A, Seed, Series C
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 35
  • Round size: Seed $1.4M–$8M; Series A $3.2M–$24M; Series C $8M–$24M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • 8fit — Get personalized workouts, custom meal plans, and nutrition guidance, right in the palm of your hand. Prioritize progress over perfection with the 8fit app!
  • Ufonia — Dora is a clinical AI agent that calls and supports your cataract patients, empowering your ophthalmology practice to scale without compromise on care.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 2 investments in United Kingdom Biotechnology startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 114
  • Round size: Seed $150k–$18M; Series A $5.8M–$36M; Series B $19M–$120M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Key AI — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
  • OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies
  • Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 2 investments in United Kingdom Biotechnology startups

Nadav Ben-Chanoch

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 169
  • Round size: Seed $329k–$5.5M; Pre-Seed $125k–$2.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We we build & operate onchain trading systems.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Dotfile — Dotfile is the Compliance Orchestration Platform for Fintechs. Streamline KYC & KYB and scale AML/CFT due diligences over +200 countries.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States · 2 investments in United Kingdom Biotechnology startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 138
  • Round size: Seed $500k–$9.3M; Pre-Seed $100k–$3.3M; Series A $4M–$31M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • ToolBelt — The only platform built specifically for licensed pros in residential construction looking for work or finding labor.
  • Scaler — Scaler empowers real estate managers to protect investments, reduce operational costs, and meet reporting obligations. Our best-in-class tech delivers faster decisions, smarter strategies, and audit-ready documentation across your entire real estate portfolio
  • OneImaging — OneImaging makes life-saving diagnostics affordable, accessible, and personal. We connect employers, health plans, and members to a trusted national network of imaging centers, delivering faster answers with transparent pricing and premium care across MRIs, CT scans, ultrasounds, mammograms, X-rays and more. We serve organizations looking to control medical spend and individuals who need reliable results without delays. Every scan booked through OneImaging is proof that healthcare can be simpler, cheaper, and kinder.
Show all investments...

Pratima Aiyagari
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Pratima is a Venture Partner at Nauta Capital and is based in London. At Nauta, Pratima focuses on enterprise software and deep tech domains.Pratima has 18+ years of professional experience. She is a software developer by background and spent several years in Silicon Valley working on developing intelligent network services in the networkmanagement domain. Pratima joins Nauta from US-based cybersecurity-focused investment firm Paladin Capital. Previously, Pratima led investments and acquisitions at Cisco Corporate Development in Europe with a specific focus on ML/AI, Enterprise Collaboration and Silicon. During her investment career, Pratima led an investment or held board seats in Aimotive, Adbrain, Evrythng, Secure Code Warrior, decentriq, Dashbird, and several fund investments. She also managed investments in several companies including Behaviosec, Italtel, ip.access, and Corvil.Pratima received her MBA from INSEAD in France and an MS in computer science from the Virginia Polytechnic Institute and State University in the US. Pratima is a co-author of a US patent in the area of network device clusters and high availability.

Show more...

Investment focus

  • Industry: Analytics, Cyber Security, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Croatia

Investor stats

  • Total investments: 8
  • Round size: Seed $1.2M–$5.5M; Pre-Seed $982k–$1.2M; Series A $12M–$12M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Mindflow — Mindflow is a No-Code & Agentic Automation & Orchestration Platform that enables all Enterprise Cyber IT Professionals to Automate Mundane tasks and to deploy AI Agents at scale.
  • ESPROFILER — ESPROFILER uniquely combines security spend, commercials, and capabilities with threats helping security leaders maximise their investments.
Show all investments...

Ariel Poler
Angel · San Francisco, California, United States · 2 investments in United Kingdom Biotechnology startups

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Show more...

Investment focus

  • Industry: Software, Social Media, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States, Spain, Mexico

Investor stats

  • Total investments: 45
  • Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
  • Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
  • Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 2 investments in United Kingdom Biotechnology startups

Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 314
  • Round size: Seed $500k–$6.6M; Pre-Seed $125k–$3.3M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Swaive — Swaive operates a financial firm that invests in risk-free instruments. The organization allows you to park your money without risk.
  • AstroForge — We mine asteroids to extract valuable minerals in space at a lower cost and smaller carbon footprint than the current terrestrial mining methods.
  • Autoplay — Autoplay is an AI-powered platform that improves digital adoption by offering real-time, context-aware guidance. It learns from user interactions and software interfaces, adapting to help enterprises optimize usage, streamline workflows, and boost engagement across teams.
Show all investments...

Paul Forster
Angel · Cambridge, Massachusetts, United States · 2 investments in United Kingdom Biotechnology startups

Paul Forster is an early-stage investor in the tech sector. He previously worked at Indeed as a Senior Advisor. Paul attended INSEAD, where he earned an MBA.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 78
  • Round size: Seed $1.1M–$7.2M; Pre-Seed $1.1M–$3.5M; Series A $3.9M–$15M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • Oraion — Your single source of truth for enterprise data
  • Stackfix — Stackfix operates as a software comparison platform.
  • Kombo — One unified API for HRIS, Payroll & ATS
Show all investments...

Mati Staniszewski
Angel · London, England, United Kingdom · 2 investments in United Kingdom Biotechnology startups

Mati Staniszewski is the Co-Founder of ElevenLabs.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Poland

Investor stats

  • Total investments: 12
  • Round size: Seed $5M–$10M; Pre-Seed $2M–$5M; Series A $16M–$40M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CodeWords
  • VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
  • Elastics — Elastics is an AI-native operating system for prediction markets and beyond. Powered by auditable AI agents, it allows traders to build and automate trading workflows in plain language, from signal generation to live execution.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Hugh Grant
Angel · Saint Louis, Missouri, United States · 2 investments in United Kingdom Biotechnology startups

Hugh Grant is President and Chief Executive Officer at Monsanto.

Show more...

Investment focus

  • Industry: Biotechnology, Machine Learning
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bactobio — At Bactobio, our mission is to create a safer and greener world by harvesting valuable metabolites from biological dark matter.
Show all investments...

Jim Mellon
Angel · 2 investments in United Kingdom Biotechnology startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 29
  • Lead/follow: no public data

Portfolio highlights

  • Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Show all investments...

Gilad Engel
Angel · 2 investments in United Kingdom Biotechnology startups

Gilad Engel

Show more...

Investment focus

  • Industry: Hardware, Analytics, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: France, Israel, United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $1.2M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Joe — Joe is an financial service that reimburses and allows ALL expenses to be paid in several installments.
  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • Fourier Optics — Fourier optics creates meta-surface based optical systems for Augmented Reality glasses
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 2 investments in United Kingdom Biotechnology startups

Robert Kopple

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Mark P. Stevenson
Angel · 1 investments in United Kingdom Biotechnology startups

Life Sciences Investor & Board member | Former EVP & COO Thermo Fisher Scientific

Show more...

Investment focus

  • Industry: Medical, Genetics, Health Care
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Show all investments...

David Rowan
Angel · London, England, United Kingdom · 1 investments in United Kingdom Biotechnology startups

David Rowan is editor of the UK edition of WIRED magazine, which won 2009 Launch of the David Rowan is Editor of the WIRED UK, the technology and trends magazine covering online brands, gadgets and the culture that surrounds them. David has reported on technology for The Times and Channel 4 News, the latter requiring him to illustrate the newiPod Video from the set of a porn shoot. He's also written for The Sunday Times and Telegraph Magazines, and edited the Guardian's on-line content. David has curated an exhibition of British creative talent at the Government's Cabinet Forum conference. He has also addressed the TEDs, and frequently contributes on Newsnight and the Today programme. He also writes a monthly column for GQ. David is in touch with many of the world's leading trend-setters and spotters. In presentations he looks at how the net is disrupting almost every sector, how apps change consumer behaviour and why 'social commerce' is killing traditional marketing. He reveals the 10 trends that will change your market in the next decade - and what you should be doing now to protect yourself.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Germany, Croatia

Investor stats

  • Total investments: 24
  • Lead/follow: no public data

Portfolio highlights

  • EWOR — EWOR is a platform dedicated to transforming aspiring entrepreneurs into successful startup founders through world-class education, mentorship, and investment opportunities.
  • Climate X — Climate X combines climate science and econometrics to deliver precise climate risk data without any black boxes.
  • Rhizocore Technologies — We develop high-performance strains of locally-sourced mycorrhizal fungi to improve tree growth, tree health and tree resiliency. We offer a sustainable solution to increase forest yields whilst improving the ability of trees to sequester carbon.
Show all investments...

Sami Mikati
Angel · 1 investments in United Kingdom Biotechnology startups

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Johnathan Matlock
Angel · Bedford, Bedfordshire, United Kingdom · 1 investments in United Kingdom Biotechnology startups

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Argonaute RNA — Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.
  • Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Show all investments...

Sarah Howell
Angel · London, England, United Kingdom · 1 investments in United Kingdom Biotechnology startups

Sarah Howell joined Arecor Limited as Chief Executive Officer in 2015.

Show more...

Investment focus

  • Industry: Biopharma, Education, Biotechnology
  • Stage:Post-IPO Equity
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Show all investments...

Mark Gillespie
Angel · Los Angeles, California, United States · 1 investments in United Kingdom Biotechnology startups

Recently named as one of Billboard’s 2021 Change Agents, as well as one of the World's Greatest Managers by Music Business Worldwide, Mark Gillespie is a world-class British CEO, manager, and producer whose vision and drive have led him to build Three Six Zero into the global entertainment powerhouse that it is today. Widely recognized as oneof the industry's preeminent executives, Gillespie has been instrumental in guiding the careers of Frank Ocean and Calvin Harris, most recently closing a deal in excess of $100MM for his publishing catalogue. With offices in Los Angeles, Miami, and London, Gillespie provides the leadership necessary to ensure that Three Six Zero and its clients remain at the forefront of the music, film, television, and digital content landscapeFueled by a lifelong passion for music, Gillespie launched his career in his hometown of Birmingham, UK, where he proved to be an invaluable asset for superclub Godskitchen. Since then, he has established himself as a visionary in the entertainment industry, having worked in partnerships with Sony Music Entertainment, Jay-Z and Roc Nation, and most recently Westbrook Entertainment, whose talent roster includes Will Smith, Jada Pinkett Smith, and the entire Smith Family.A relentless pioneer and entrepreneur, Gillespie has joined forces with Pete Tong MBE to run Three Six Zero Recordings, his own in-house record label, while continuing to expand an already successful presence in film and television. Along with several other projects in the pipeline, the company's first feature film – prestige drama, VOX LUX – starring Natalie Portman and Jude Law, including an original soundtrack by Sia, was released in 2018.With a passion for innovation at the intersection of media, technology, and apparel, Gillespie has invested in companies such as Outdoor Voices, Stance, Ember Technologies, Stem Disintermedia, and Saavn. Committed to giving back and continuously fostering artistic talent, Gillespie has also remained a longtime philanthropist and advocate, sitting on both the Music Committee of Children in Conflict and the core screening panel of the Recording Academy. In his downtime, Gillespie enjoys following Manchester United and is an avid collector of modern art.

Show more...

Investment focus

  • Industry: Music, Internet, Video
  • Stage:Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • Bkstg — Bkstg was founded by tech and music entrepreneurs to reinvent the way artists and fans connect by creating a new form of direct relationship that’s never existed before.
  • Hyperice — HyperIce is a recovery and movement enhancement technology company specializing in vibration, percussion, and thermal technology. Its technology is used by the athletes in professional and collegiate training rooms and fitness facilities globally.The company is driven by a mission to provide everyone with the innovative technology in acceleratingrecovery time, preventing injury, and enhancing the body’s ability to move efficiently. HyperIce was founded in 2010 by Anthony Katz.
  • Biosceptre — A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Brad Wilson
Angel · Plymouth Meeting, Pennsylvania, United States · 1 investments in United Kingdom Biotechnology startups

Brad Wilson Global Product Director at GlaxoSmithKline.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Machine Learning
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • OxCan — Enabling curative cancer treatment through early detection
Show all investments...

Martin Chavez
Angel · New York, New York, United States · 1 investments in United Kingdom Biotechnology startups

Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985.

Show more...

Investment focus

  • Industry: Health Care, Machine Learning, Biotechnology
  • Stage:Series A, Seed, Private Equity
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Hebbia — Hebbia's neural search lets you execute research 10X faster and 10X more accurately. Transform your productivity today.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • VMind AI — VMind is a frontier technology company building artificial general intelligence (AGI).
Show all investments...

Ahmed Medhat
Angel · San Francisco, California, United States · 1 investments in United Kingdom Biotechnology startups

Ahmed Medhat - Research Scientist, Core Data Science @ Meta

Show more...

Investment focus

  • Industry: Information Technology, Apps, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • Ntropy Network — Unlock the power of transactions. Our technology enables flexible and autonomous banking data cleansing, labeling and enhancement.
  • OASIS AI — All you do is talk. AI does the rest.
  • Grin Gaming — GrinData micro markets software leverages best-in-class high-frequency trading and machine learning to deliver reliable odds pricing on the most markets.
Show all investments...

Huw Bishop
Angel · 1 investments in United Kingdom Biotechnology startups

Huw Bishop is an individual investor.

Show more...

Investment focus

  • Industry: EdTech, Training, E-Learning
  • Stage:Angel
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • clear_pixel VR — Virtual reality training platform that helps increase your laboratory skills and reduces laboratory breakages and costs
Show all investments...

Sam Harris
Angel · 1 investments in United Kingdom Biotechnology startups

Sam Harris

Show more...

Investment focus

  • Industry: Wellness, Elder Care, Health Care
  • Stage:Pre-Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Decorte Future Industries — DFI augments humanity through intelligent clothing. We care for the most vulnerable and empower those pushing the edges of human ability.
Show all investments...

Dave DeWalt
Angel · San Francisco, California, United States · 1 investments in United Kingdom Biotechnology startups

David G. DeWalt is the Founder and Managing Director of Dave DeWalt. He joined AllegisCyber Capital as a Managing Director in 2017. Dave is a renowned cybersecurity executive, having taken cyber industry leader FireEye public (Chairman & CEO) and served as the CEO of both McAfee and Documentum.He is a member or leader of six boards ofdirectors, including ForgeRock, ForeScout, Phantom Cyber, and OPTIV, and serves as the Vice Chairman of Delta Airlines. Dave consults regularly with government, industry players, and the corporate Board of Directors on matters related to cybersecurity policy, technology, and strategy.He holds a B.S. in computer science from the University of Delaware.

Show more...

Investment focus

  • Industry: Cyber Security, Security, Network Security
  • Stage:Series C, Series A
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Callsign — Marking a new era in passive authentication, fraud prevention and intelligence. We make digital identity simple and more secure.
  • Instant Channel — Instant Channel, Inc. is an advertising and marketing company that provides email marketing and communications services in the State of California.
  • Blackbird.AI — Blackbird.AI provides organizations with Deception Detection technology to protect against narrative manipulation and disinformation.
Show all investments...

Peer Schatz
Angel · Düsseldorf, Nordrhein-Westfalen, Germany · 1 investments in United Kingdom Biotechnology startups

1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

Show more...

Investment focus

  • Industry: Medical, Genetics, Health Care
  • Stage:Seed
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Valar Labs — AI to Make Oncologists Smarter
  • Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Show all investments...

Susan Lowther
Angel · Cambridge, Cambridgeshire, United Kingdom · 1 investments in United Kingdom Biotechnology startups

Susan joined IXICO as Chief Financial Officer in October 2014. She is an experienced Executive Director with previous Board positions including Group Chief Financial Officer of Novacyt SA and Chief Financial Officer of Lab21 prior to its acquisition by Novacyt. Susan was Chief Financial Officer of BioWisdom until its acquisition by Instem plc andFinance Director of RiboTargets Limited until its acquisition by Vernalis plc.

Show more...

Investment focus

  • Industry: Biopharma, Education, Biotechnology
  • Stage:Post-IPO Equity
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Show all investments...

Sam Fazeli
Angel · London, England, United Kingdom · 1 investments in United Kingdom Biotechnology startups

Sam Fazeli is the Non Executive Director at Arecor Limited.

Show more...

Investment focus

  • Industry: Biopharma, Education, Biotechnology
  • Stage:Post-IPO Equity
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Arecor — Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides.In addition toits internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
Show all investments...

Silla Scheepens
Angel · 1 investments in United Kingdom Biotechnology startups

Silla Scheepens of Future Food Fund.

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing, Food and Beverage
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Extracellular — Extracellular is a scale-up and development partner, channelling biology, digitalisation and biomanufacturing expertise to accelerate the potential of cultivated meat.
Show all investments...

Biotechnology Angel investor funding in United Kingdom at a glance

Stats across 161 deals from 178 investors.

178
investors
in United Kingdom Biotechnology startups
161
deals
in United Kingdom Biotechnology startups
$3.8M
median round
in United Kingdom Biotechnology startups
6%
lead investors
lead at least one round
42%
Seed
most common funding stage

Access all 178 angel investors in United Kingdom Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 178 angel investors investing in United Kingdom Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists